| 000 | 01415 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517182200.0 | ||
| 264 | 0 | _c20171031 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1791-7530 | ||
| 024 | 7 |
_a10.21873/anticanres.12050 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUrey, Carlos | |
| 245 | 0 | 0 |
_aDevelopment and _h[electronic resource] |
| 260 |
_bAnticancer research _c11 2017 |
||
| 300 |
_a6031-6039 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCarcinoma, Pancreatic Ductal _xdrug therapy |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLiposomes _xadministration & dosage |
| 650 | 0 | 4 |
_aMucin-4 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aHilmersson, Katarzyma Said | |
| 700 | 1 | _aAndersson, Bodil | |
| 700 | 1 | _aAnsari, Daniel | |
| 700 | 1 | _aAndersson, Roland | |
| 773 | 0 |
_tAnticancer research _gvol. 37 _gno. 11 _gp. 6031-6039 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.21873/anticanres.12050 _zAvailable from publisher's website |
| 999 |
_c27714082 _d27714082 |
||